文章摘要
王伟,孙强三,徐少华,柳相珍,王晓红.超短波辅助治疗慢性阻塞性肺疾病患者气道炎症的临床研究[J].中华物理医学与康复杂志,2003,(8):.-
扫码阅读全文 本文二维码信息
超短波辅助治疗慢性阻塞性肺疾病患者气道炎症的临床研究
  
DOI:
中文关键词: 超短波  慢性阻塞性肺疾病  气道炎症  肺功能
英文关键词: Ultrashortwave  COPD  Airway inflammation  Lung function
基金项目:
作者单位
王伟,孙强三,徐少华,柳相珍,王晓红 250033济南山东大学第二医院呼吸内科(王伟、徐少华、柳相珍)康复医学科(孙强三、王晓红) 
摘要点击次数: 3870
全文下载次数: 3662
中文摘要:
      目的研究超短波对慢性阻塞性肺疾病(COPD)患者气道炎症及肺通气功能的影响并探讨其作用机理。 方法将74例急性发作期COPD患者分为超短波治疗组42例和对照组32例。超短波治疗组在常规治疗的基础上给予超短波治疗,对照组行常规治疗。两组患者均在治疗前、后分别记录其临床症状及体征,并检测血中白介素8 (IL-8)、肿瘤坏死因子α(TNF-α)、粒细胞集落刺激因子(G-CSF)以及肺通气功能指标中用力肺活量(FVC)和第1秒用力呼气量(FEV1.0)。 结果与对照组比较,超短波治疗组治疗后其咳嗽、痰液性状、痰量及干啰音等临床症状与体征的显效好转率显著提高(P<0.05),血清IL-8、TNF-α、G-CSF均显著降低(P<0.05),FVC%pred、FEV1.0%pred 明显升高(P<0.05)。IL-8含量与FEV1.0呈负相关(r=-0.87,P<0.05),TNF-α含量与FEV1.0呈负相关(r=-0.72,P<0.05)。 结论超短波辅助治疗COPD具有减轻气道炎症、提高肺通气功能的作用。
英文摘要:
      Objective To investigate the effect of ultrashortwave therapy on chronic obstructive pulmonary disease(COPD),and to explore the mechanism of ultrashortwave on COPD. MethodsSeventy-four patients were divided into 2 groups: a treatment group, in which 42 patients were treated with both ultrashortwave and regular treatment; a control group, in which 32 patients were treated with only regular treatment. Clinical symptoms and signs were recorded,the serum samples were obtained and pulmonary function indices such as FVC and FEV1.0 were tested before and after the treatment, respectively. The interleukin-8 (IL-8), tumor necrosis factor-alpha (TNF-α) and granulocyte colony-stimulating factor(G-CSF) in serum were determined by immunoassay technique. The relationship between IL-8,TNF-α,G-CSF and FVC,FEV1.0 were analysed. ResultsCompared with that of control group,the clinical manifestations were improved and the IL-8,TNF-α,G-CSF were decreased more significantly after the treatment with ultrashortwave(P<0.05). FVC,FEV1.0 increased more significantly in the treatment group than in control group(P<0.05).FVC and FEV1.0 is negatively relative to IL-8(r=-0.87,P<0.05)and TNF-α(r=-0.72,P<0.05). ConclusionUltrashortwave therapy is effective for improving the ventilation by antiinflammation in airway in COPD patients.
查看全文   查看/发表评论  下载PDF阅读器
关闭